IAA5 acts as a transcriptional repressor in auxin signaling by interacting with Auxin Response Factors (ARFs). Key findings include:
DNA Damage Response: IAA5 is locally induced in Arabidopsis root vascular stem cells under DNA stress (e.g., bleomycin treatment), promoting stem cell death to maintain genome integrity .
Auxin Signaling Modulation:
While no studies directly describe the IAA5 antibody, its inferred uses based on related research include:
Induction Dynamics:
Mutant Phenotypes:
Antibody Validation:
Experimental Systems:
Antibody Development: No peer-reviewed studies explicitly describe IAA5 antibody generation or validation.
Translational Potential:
Western blotting with validated IAA5-specific antibodies is the gold standard for quantifying protein levels. Include controls such as iaa5 knockout mutants to confirm antibody specificity.
Immunoprecipitation (IP) coupled with mass spectrometry identifies IAA5 interaction partners (e.g., ARF10/16) under auxin treatment or stress conditions .
Cycloheximide chase assays assess IAA5 protein stability. For example, IAA5 degradation occurs within 30 minutes of auxin treatment, which is delayed by proteasome inhibitors like MG132 .
Use double mutants (e.g., iaa5 iaa29) to bypass functional redundancy .
Employ tissue-specific promoters (e.g., WOL for vascular stem cells) to express stabilized IAA5 variants (e.g., IAA5) and observe phenotypic rescue .
Combine with transcriptional reporters (e.g., DR5::LUC) to monitor auxin response dynamics .
Competitive binding assays: In vitro pull-downs show IAA33 reduces IAA5-ARF10/16 interactions by 60–80%, suggesting direct competition .
Yeast three-hybrid systems demonstrate that co-expression of IAA33 blocks IAA5-ARF binding, while IAA5 does not reciprocally inhibit IAA33-ARF interactions .
Table 1: Key interactions between IAA5, IAA33, and ARFs
Temporal analysis: IAA5 transcript levels rise within 6 hours of DNA damage (e.g., bleomycin treatment), preceding stem cell death at 12–18 hours . Use time-course qRT-PCR and PI staining to correlate expression with phenotype.
Tissue-specific mutants: sog1-101 knockout abolishes IAA5 induction, confirming dependence on the SOG1 transcription factor .
Epitope mapping: Validate antibody reactivity against conserved domains (e.g., Domain II in IAA5) using peptide arrays.
Phylogenetic analysis: Test antibody cross-reactivity with AUX/IAA homologs in closely related species (e.g., Brassica).
Quantitative thresholds: For auxin-treated samples, define degradation kinetics (e.g., IAA5 half-life <30 minutes) .
Stress-specific controls: Include non-DNA-damaging stressors (e.g., salt, heat) to isolate IAA5’s role in genome integrity .
Data normalization: Use housekeeping genes like ACTIN2 for qRT-PCR and Coomassie staining for Western blots to account for loading variability.